entertainment -WSS

entertainment

author：entertainment 2025-09-30 19:26:54 - browse：9688

Sammy Kimball for STAT

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss what some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

For more on what we cover, here’s the news on Celsius Therapeutics; here’s more on EQRx; here’s the latest on Apellis Pharmaceuticals; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Pancreatic cancer early detection could be helped by AI

WSS

The stock market has soared this year, but will it last? Experts weigh in

Hormonal contraceptives don’t actually treat endometriosis

Merck CEO won’t testify in Senate, citing no expertise in drug prices

US jobless claims fall again as labor market continues to flash strength

There’s a way to spot data fakery. All journals should be using it

Judge denies Trump's request for new trial in E. Jean Carroll case

focus

entertainment

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Virginia high school admissions case could be legal follow

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Medical leaders decry Supreme Court decision on affirmative action

Syphilis numbers in the United States reach record heights

Bright Health sells Medicare Advantage business to Molina

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Hollywood unions extend contract negotiations for actors

Readout Newsletter: The latest on Novavax, Merck, Bluebird

knowledge

How a Boston hospital is priming medical residents to use GPT

The stock market has soared this year, but will it last? Experts weigh in

Biogen walks away from Aduhelm, years after polarizing approval

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

10 reasons why health care startups fail

FTC sues over Novant Health acquisition of two N.C. hospitals

Wikipedia

leisure time

focus

focus